IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-48441-8.html
   My bibliography  Save this article

Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression

Author

Listed:
  • Jong Ho Park

    (Massachusetts General Hospital and Harvard Medical School
    Massachusetts General Hospital and Harvard Medical School
    Keimyung University)

  • Mahsa Mortaja

    (Massachusetts General Hospital and Harvard Medical School
    Massachusetts General Hospital and Harvard Medical School)

  • Heehwa G. Son

    (Massachusetts General Hospital and Harvard Medical School
    Massachusetts General Hospital and Harvard Medical School)

  • Xutu Zhao

    (Massachusetts General Hospital and Harvard Medical School
    Massachusetts General Hospital and Harvard Medical School)

  • Lauren M. Sloat

    (Massachusetts General Hospital and Harvard Medical School
    Massachusetts General Hospital and Harvard Medical School)

  • Marjan Azin

    (Massachusetts General Hospital and Harvard Medical School
    Massachusetts General Hospital and Harvard Medical School)

  • Jun Wang

    (Massachusetts General Hospital and Harvard Medical School)

  • Michael R. Collier

    (Massachusetts General Hospital and Harvard Medical School)

  • Krishna S. Tummala

    (Massachusetts General Hospital and Harvard Medical School
    Massachusetts General Hospital
    Harvard Medical School
    Broad Institute of Massachusetts Institute of Technology and Harvard)

  • Anna Mandinova

    (Massachusetts General Hospital and Harvard Medical School)

  • Nabeel Bardeesy

    (Massachusetts General Hospital and Harvard Medical School
    Massachusetts General Hospital
    Harvard Medical School
    Broad Institute of Massachusetts Institute of Technology and Harvard)

  • Yevgeniy R. Semenov

    (Massachusetts General Hospital and Harvard Medical School
    Harvard Program in Therapeutic Science, Harvard Medical School)

  • Mari Mino-Kenudson

    (Massachusetts General Hospital and Harvard Medical School)

  • Shadmehr Demehri

    (Massachusetts General Hospital and Harvard Medical School
    Massachusetts General Hospital and Harvard Medical School
    Massachusetts General Hospital and Harvard Medical School)

Abstract

Chronic inflammation is a major cause of cancer worldwide. Interleukin 33 (IL-33) is a critical initiator of cancer-prone chronic inflammation; however, its induction mechanism by environmental causes of chronic inflammation is unknown. Herein, we demonstrate that Toll-like receptor (TLR)3/4-TBK1-IRF3 pathway activation links environmental insults to IL-33 induction in the skin and pancreas inflammation. An FDA-approved drug library screen identifies pitavastatin to effectively suppress IL-33 expression by blocking TBK1 membrane recruitment/activation through the mevalonate pathway inhibition. Accordingly, pitavastatin prevents chronic pancreatitis and its cancer sequela in an IL-33-dependent manner. The IRF3-IL-33 axis is highly active in chronic pancreatitis and its associated pancreatic cancer in humans. Interestingly, pitavastatin use correlates with a significantly reduced risk of chronic pancreatitis and pancreatic cancer in patients. Our findings demonstrate that blocking the TBK1-IRF3-IL-33 signaling axis suppresses cancer-prone chronic inflammation. Statins present a safe and effective prophylactic strategy to prevent chronic inflammation and its cancer sequela.

Suggested Citation

  • Jong Ho Park & Mahsa Mortaja & Heehwa G. Son & Xutu Zhao & Lauren M. Sloat & Marjan Azin & Jun Wang & Michael R. Collier & Krishna S. Tummala & Anna Mandinova & Nabeel Bardeesy & Yevgeniy R. Semenov &, 2024. "Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-48441-8
    DOI: 10.1038/s41467-024-48441-8
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-48441-8
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-024-48441-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Yi Sun & Or-yam Revach & Seth Anderson & Emily A. Kessler & Clara H. Wolfe & Anne Jenney & Caitlin E. Mills & Emily J. Robitschek & Thomas G. R. Davis & Sarah Kim & Amina Fu & Xiang Ma & Jia Gwee & Pa, 2023. "Targeting TBK1 to overcome resistance to cancer immunotherapy," Nature, Nature, vol. 615(7950), pages 158-167, March.
    2. Direna Alonso-Curbelo & Yu-Jui Ho & Cassandra Burdziak & Jesper L. V. Maag & John P. Morris & Rohit Chandwani & Hsuan-An Chen & Kaloyan M. Tsanov & Francisco M. Barriga & Wei Luan & Nilgun Tasdemir & , 2021. "A gene–environment-induced epigenetic program initiates tumorigenesis," Nature, Nature, vol. 590(7847), pages 642-648, February.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jonas Engesser & Robin Khatri & Darius P. Schaub & Yu Zhao & Hans-Joachim Paust & Zeba Sultana & Nariaki Asada & Jan-Hendrik Riedel & Varshi Sivayoganathan & Anett Peters & Anna Kaffke & Saskia-Lariss, 2024. "Immune profiling-based targeting of pathogenic T cells with ustekinumab in ANCA-associated glomerulonephritis," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
    2. Yuanyuan Chen & Reka Toth & Sara Chocarro & Dieter Weichenhan & Joschka Hey & Pavlo Lutsik & Stefan Sawall & Georgios T. Stathopoulos & Christoph Plass & Rocio Sotillo, 2022. "Club cells employ regeneration mechanisms during lung tumorigenesis," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    3. Yi Xu & Michael H. Nipper & Angel A. Dominguez & Zhenqing Ye & Naoki Akanuma & Kevin Lopez & Janice J. Deng & Destiny Arenas & Ava Sanchez & Francis E. Sharkey & Colin M. Court & Aatur D. Singhi & Hua, 2024. "Reconstitution of human PDAC using primary cells reveals oncogenic transcriptomic features at tumor onset," Nature Communications, Nature, vol. 15(1), pages 1-16, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-48441-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.